Journal profile · ONCOLOGY
Memo-Magazine of European Medical Oncology
ISSN 1865-5041 · eISSN 1865-5076 · Springer Nature · 4 issues per year
Memo-Magazine of European Medical Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.6 (journal website); hybrid open access; APC about USD 4,790; median 61 days to acceptance (74 articles, last 24 months); 75 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Memo-Magazine of European Medical Oncology is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Chronic Lymphocytic Leukemia Research, together about 21.8% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO). The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Wolfgang HilbePublisher website
Editorial board by country: none in mainland China; most named Austria 41, Switzerland 5, Poland 4, Greece 4, Romania 4 (84 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine7.7%
- Lung Cancer Treatments and MutationsMedicine7.3%
- Chronic Lymphocytic Leukemia ResearchMedicine6.8%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.8%
- Acute Myeloid Leukemia ResearchMedicine4.9%
- Gastric Cancer Management and OutcomesMedicine4.9%
- Colorectal Cancer Treatments and StudiesMedicine4.8%
- Cancer Immunotherapy and BiomarkersMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 0.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.4Publisher website ·
- CiteScore 2026-06
- 1.2LetPub ·
- SJR 2026-06
- 0.28LetPub ·
- SNIP 2026-06
- 0.17LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 82OpenAlex ·
- 2-year mean citedness
- 0.77OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 62.92%LetPub ·
Volume
- Articles per year
- 65LetPub ·
- Downloads per year (publisher) 2025
- 249,900Publisher website ·
Articles by year OpenAlex count · 1,415 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 38 | 28 | 6 |
| 2025 | 75 | 48 | 45 |
| 2024 | 68 | 48 | 88 |
| 2023 | 87 | 70 | 103 |
| 2022 | 75 | 48 | 113 |
| 2021 | 110 | 82 | 439 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
61 daysMedian, submission to acceptance · P25–P75 39 days – 79 days
- Acceptance to online
- median 31 days (90 articles)
- Submission to online
- median 89 days
- Sample
- 74 articles with submission and acceptance dates (132 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 1 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,690 / GBP 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 2,000 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted18, with length limits
- case reportEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…main text ≤ 1,000 words
- case reportsCase reports should include a concise literature review and are limited to 1,000 words and 20 citations. Images are welcome.Length not stated
- comments on a specific articleComments on a specific article are limited to 500 words and 5 citations.Length not stated
- comments on important abstractsComments on important abstracts presented at leading meetings or congresses are appreciated (limited to 300 words, 2 citations).Length not stated
- controversiesControversies should focus on one single topic of interest and are limited to 1,000 words and 20 citations.Length not stated
- correspondenceEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…Length not stated
- correspondence (letters to the editor)Correspondence (Letters to the Editor) are welcome (limited to 300 words).Length not stated
- editorialEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…Length not stated
- editorialsEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…Length not stated
- letters to the editorEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…Length not stated
- literature reviewEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…Length not stated
- original reportsOriginal reports are limited to 2,000 words of body text, excluding the abstract, references, figures, and tables. Original Reports are limited to six total fig…Length not stated
- perspectivesPerspectives are written only at the invitation of the Editor-in-Chief and Editorial Board.Length not stated
- reviewEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…Length not stated
- review articleEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…Length not stated
- short reviewEditorials are in general invited by the Editor-in-Chief with the intention to accompany an accepted manuscript and should contain no more than 500 words in len…main text ≤ 1,500 words
- special articlesSpecial articles may include, but are not limited to, guidelines, summaries of consensus meetings, and other scholarly communications.Length not stated
- supplementsSupplements: Abstracts of congresses or reviews of presentations and lectures given at meetings or congresses are moderated by guest editors.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein.
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
Authors must indicate whether or not there is a financial relationship between them and the organization that sponsored the research. Model summary
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability
Data transparency: all data, materials, software or custom code must support published claims and comply with field standards. Model summary
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards.
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Human studies must be approved by an ethics committee and performed in accordance with the 1964 Declaration of Helsinki. Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide.
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in memo - Magazine of European Medical Oncology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Manuscript acceptance is based on originality, quality and priority of the work. Model summary
Manuscript acceptance in Memo – Magazine of European Medical Oncology is based on originality, quality and priority of the work.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 1865-5041
- Electronic ISSN
- 1865-5076
- Society / sponsor
- Central European Cooperative Oncology Group
- Latest issue on the website
- Volume 19, Issue 2 (May 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Memo-Magazine of European Medical Oncology
What CAS zone is Memo-Magazine of European Medical Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Memo-Magazine of European Medical Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Memo-Magazine of European Medical Oncology?
The journal's website gives an impact factor of 0.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1.2, h-index 26.
How long does peer review take at Memo-Magazine of European Medical Oncology?
Based on the dates recorded on 74 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 61 days (interquartile range 39–79 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Memo-Magazine of European Medical Oncology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 2,000 words; Reference style: Numbered, in order of citation; Templates: LaTeX and Word; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Memo-Magazine of European Medical Oncology based?
Of the 84 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Austria (41), Switzerland (5) and Poland (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Memo-Magazine of European Medical Oncology?
According to LetPub and DOAJ records, Memo-Magazine of European Medical Oncology is indexed in ESCI and Scopus. The journal's website also lists Embase; that list has not been checked against each database.
Is Memo-Magazine of European Medical Oncology open access, and what is the APC?
Memo-Magazine of European Medical Oncology is a hybrid journal. For open-access publication: APC about USD 4,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .